Phibro Animal Health (PAHC) Exchange Rate Effect (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Exchange Rate Effect came in at $2.3 million in Q1 2026, up 290.5% year-on-year from $600000.0 in Q1 2025, and up 597.45% quarter-over-quarter from -$471000.0 in Q4 2025.
Phibro Animal Health (PAHC) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Phibro Animal Health's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 290.5% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 203.84% increase from a year earlier, with the FY2025 full-year figure at -$1.1 million, up 65.33% from the prior year.
- Exchange Rate Effect climbed to $2.3 million in Q1 2026 per PAHC's latest filing, from -$471000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.3 million in Q1 2026 and bottomed at -$3.7 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is $50000.0 (2023), against an average of -$101411.8.
- Across the five-year window, Exchange Rate Effect tumbled 400.0% in 2023 and surged 537.96% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $725000.0 in 2022, then tumbled by 400.0% to -$2.2 million in 2023, then tumbled by 69.47% to -$3.7 million in 2024, then jumped by 87.22% to -$471000.0 in 2025, then surged by 597.45% to $2.3 million in 2026.
- Per Business Quant, the three latest PAHC Exchange Rate Effect figures stand at $2.3 million (Q1 2026), -$471000.0 (Q4 2025), and $107000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -471,000.00 |
| Dec 31, 2025 | -471,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -3.69 Mn |
| Dec 31, 2024 | -3.69 Mn |
| Sep 30, 2024 | 729,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | -717,000.00 |
| Jun 30, 2024 | -717,000.00 |
| Mar 31, 2024 | -137,000.00 |
| Mar 31, 2024 | -137,000.00 |
| Dec 31, 2023 | -2.18 Mn |
| Dec 31, 2023 | -2.18 Mn |